Fenofibrate enhances CD36 mediated endocytic uptake and degradation of oxidized low density lipoprotein in adipocytes from hypercholesterolemia rabbit

Atherosclerosis

Volumn 177, Issue 2, 2004, Pages 255-262

  Zhao, Shui Ping ^a   Wu, Jie ^a   Zhang, Da Qing ^a   Ye, Hui Jun ^a   Liu, Ling ^a   Li, Jie Qi ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adipocytes; CD36; Fenofibrate; OxLDL; PPAR

Indexed keywords

FENOFIBRATE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; LIPID OXIDATION; LYSOSOME MEMBRANE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADIPOCYTES; ANIMALS; ANTIGENS, CD36; ANTILIPEMIC AGENTS; CELLS, CULTURED; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; MALE; OXIDATION-REDUCTION; PROCETOFEN; RABBITS;

EID: 8644287504     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2004.07.015     Document Type: Article

References (30)

1. N.A. Abumrad, M.R. El-Maghrabi, E.Z. Amri, E. Lopez, and P.A. Grimaldi Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is included during preadipocyte differentiation. Homology with human CD36 J Biol Chem 268 1993 17665 17668
2. T.J. Aitman, A.M. Glazier, and C.A. Wallace Identification of CD36 (fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats Nat Genet 21 1999 76 83
3. M. Febbraio, N.A. Abumrad, and D.P. Hajjar A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism J Biol Chem 274 1999 19055 19062
4. G. Endemann, L.W. Stanton, and K.S. Madden CD36 is a receptor for oxidized low density lipoprotein J Biol Chem 268 1993 221 236
5. P. Tontonoz, L. Nagy, J.G.A. Alvarez, V.A. Thomazy, and R.M. Evans PPARγ promotes monocyte macrophage differentiation and uptake of oxidized LDL Cell 93 1998 241 252
6. I. Pineda Torra, P. Gervois, and B. Staels Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging Curr Opin Lipidol 10 1999 151 159
7. 2+-superoxide dismutase in the liver Life Sci 63 1998 135 144
8. A. Cabrero, M. Alegret, and R.M. Sanchez Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes Diabetes 50 2001 1883 1890
9. M. Rodbell Effects of hormones on glucose metabolism and lipolysis J Biol Chem 239 1963 375 380
10. H.H. Zhang, S. Kumar, A.H. Barnett, and M.C. Eggo Ceiling culture of mature human adipocytes: use in studies of adipocyte functions J Endocrinol 164 2 2000 119 128
11. P.R. Salacinski, C. Mclean, J.E. Sykes, V. Clement-Jones, and P. Lowry Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent 3,4,6-tetrachloro-3-alpha, 6-alpha-diphenyl glycoluril (Iodogen) J Anal Biochem 117 1981 136 146
12. J.R. Hessler, D.W. Morel, L.J. Lewis, and G.M. Chisolm Lipoprotein oxidation and lipoprotein-induced cytotoxicity Atherosclerosis 3 1983 215 222
13. N. Ohgami, R. Nagai, and M. Ikemoto CD36, a member of the class B scavenger receptor family as a receptor for advanced glycation end products J Biol Chem 276 2001 3195 3202
14. T.J. Van Berkel, Y.B. De Rijke, and J.K. Kruijt Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells J Biol Chem 266 1991 2282 2289
15. L.L. Leung, W.X. Li, J.L. McGregor, G. Albrecht, and R.J. Howard CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction J Biol Chem 267 25 1992 18244 18250
16. M. Janabi, S. Yamashita, and K. Hirano Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients Arterioscler Thromb Vasc Biol 20 8 2000 1958 1960
17. A. Kuniyasu, S. Hayashi, and H. Nakayama Adipocytes recognize and degrade oxidized low density lipoprotein through CD36 Biochem Biophys Res Commun 295 2 2002 319 323
18. S. Ehara, M. Ueda, and T. Naruko Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 15 2001 1955 1960
19. P. Holvoet, A. Mertens, and P. Verhamme Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease Arterioscler Thromb Vasc Biol 21 2001 844 848
20. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
21. P. Holvoet, and D. Collen Oxidized lipoprotein in atherosclerosis and thrombosis FASEB J. 8 1994 1279 1284
22. A.M. Tershakovec, A.F. Jawad, and N.O. Stouffer Persistent hypercholesterolemia is associated with the development of obesity among girls: the Bogalusa heart study Am J Clin Nutr 76 2002 730
23. H.B. Rubins, S.J. Robins, and D. Collins Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans affairs high-density lipoprotein cholesterol intervention trial N Engl J Med 341 6 1999 410 418
24. H. Duez, Y.S. Chao, and M. Hernandez Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice J Biol Chem 277 50 2002 48051 48057
25. P. Ambrosi, and I. Juhan-Vague Dyslipidemia, lipid lowering drugs and thrombosis Arch Mal Coeur Vaiss 88 11 1995 1641 1645
26. M. Guerre-Millo, P. Gervois, and E. Raspe Peroxisome proliferator- activated receptor alpha activators improve insulin sensitivity and reduce adiposity J Biol Chem 275 22 2000 16638 16642
27. H.J. Lee, S.S. Choi, and M.K. Park Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats Biochem Biophys Res Commun 296 2 2002 293 299
28. P. Tontonoz, E. Hu, R.A. Graves, A.I. Budavari, and B.M. Spiegelman mPPARγ2: tissue specific regulator of an adipocyte enhancer Genes Dev. 8 1994 1224 1234
29. E.D. Rosen, P. Sarraf, and A.E. Troy PPARγ is required for the differentiation of adipose tissue in vivo and in vitro Mol Cell 4 1999 611 617
30. N. Hennuyer, P. Poulain, and L. Madsen Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response Circulation 99 18 1999 2445 2451